Operating income · 2018–2025

Arcutis Biotherapeutics operating income

−$12.2M+$116M · FY2025

Arcutis Biotherapeutics (ARQT) reported −$12.2M in operating income for fiscal 2025, +$116M from the year before.

−$19.7M2018−$43.1M2019−$137M2020−$207M2021−$302M2022−$241M2023−$128M2024−$12.2M2025
Arcutis Biotherapeutics — Operating income, 2018–2025
Fiscal yearOperating incomeChangeFiling
FY20252025-12-31−$12.2M+$116MOpen →
FY20242024-12-31−$128M+$113MOpen →
FY20232023-12-31−$241M+$60.5MOpen →
FY20222022-12-31−$302M−$95.1MOpen →
FY20212021-12-31−$207M−$69.9MOpen →
FY20202020-12-31−$137M−$93.5MOpen →
FY20192019-12-31−$43.1M−$23.4MOpen →
FY20182018-12-31−$19.7M—Open →

Operating income — Operating income is profit from the core business before interest and tax. It strips out financing decisions, so it compares operations rather than balance sheets.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026

Operating income at companies of similar size

Full ranking by operating income →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Arcutis Biotherapeutics operating income |url=https://companiesranked.com/en/company/arcutis-biotherapeutics/operating-income |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Arcutis Biotherapeutics operating income. CompaniesRanked. https://companiesranked.com/en/company/arcutis-biotherapeutics/operating-income

BibTeX

@misc{companiesranked-en-company-arcutis-biotherapeutics-operating-income-2026,
  author       = {{CompaniesRanked}},
  title        = {{Arcutis Biotherapeutics operating income}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/arcutis-biotherapeutics/operating-income}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-K · 0001787306-26-000018 · February 25, 2026

{{cite web |title=Arcutis Biotherapeutics operating income — 10-K (0001787306-26-000018) |url=https://www.sec.gov/Archives/edgar/data/1787306/000178730626000018/arqt-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-25}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Arcutis Biotherapeutics overview